What analysts say about ORGO stock - Superior stock selection - Jammu Links News
8 hours ago • Google News
Organogenesis Holdings Inc (ORGO)
US$ 3.7-4.88%
Price Chart
Key Statistics
Market Cap
$ 553.08M
P/E Ratio
0.00
Revenue (TTM)
$ 458.76M
Volume
1.1M
52W High
$ 6.71
52W Low
$ 2.28
Dividend Yield
0.00%
Beta
1.64
Technicals
50-Day MA
3.5959
200-Day MA
3.7047
52 Week High
6.71
52 Week Low
2.28
About ORGO
Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United St.
Employees
869
Headquarters
Canton, MA
CEO
Mr. Gary S. Gillheeney Sr.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg